Hiroko Nagao‐Kitamoto

3.4k total citations · 2 hit papers
27 papers, 2.3k citations indexed

About

Hiroko Nagao‐Kitamoto is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Hiroko Nagao‐Kitamoto has authored 27 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Surgery. Recurrent topics in Hiroko Nagao‐Kitamoto's work include Gut microbiota and health (14 papers), Inflammatory Bowel Disease (5 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Hiroko Nagao‐Kitamoto is often cited by papers focused on Gut microbiota and health (14 papers), Inflammatory Bowel Disease (5 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Hiroko Nagao‐Kitamoto collaborates with scholars based in United States, Japan and France. Hiroko Nagao‐Kitamoto's co-authors include Nobuhiko Kamada, Sho Kitamoto, Peter Kuffa, Thomas M. Schmidt, Atsushi Hayashi, Merritt Gillilland, John Y. Kao, Kathryn A. Eaton, Jin Imai and Kohei Sugihara and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Hiroko Nagao‐Kitamoto

26 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis

2020 459 citations Sho Kitamoto, Hiroko Nagao‐Kitamoto et al. Cell profile →
The Bacterial Connection between the Oral Cavity and the Gut Diseases

2020 273 citations Sho Kitamoto, Hiroko Nagao‐Kitamoto et al. profile →

Peers

Countries citing papers authored by Hiroko Nagao‐Kitamoto

Since Specialization

Citations

This map shows the geographic impact of Hiroko Nagao‐Kitamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Nagao‐Kitamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Nagao‐Kitamoto more than expected).

Fields of papers citing papers by Hiroko Nagao‐Kitamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Nagao‐Kitamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Nagao‐Kitamoto. The network helps show where Hiroko Nagao‐Kitamoto may publish in the future.

Co-authorship network of co-authors of Hiroko Nagao‐Kitamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Nagao‐Kitamoto. A scholar is included among the top collaborators of Hiroko Nagao‐Kitamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Nagao‐Kitamoto. Hiroko Nagao‐Kitamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transmission of maternal oral pathobionts to the infant gut predisposes offspring to exacerbated enteritis 2025 ·Cell Reports ·(unknown), Yeji Kim, (unknown), Kyoko Yamazaki, Kira L. Newman, Merritt Gillilland, Yijie Guo, Daisuke Watanabe, Ingrid L. Bergin, Takehiro Suzuki, Daisuke Motooka, Kohei Sugihara, Sho Kitamoto, Hiroko Nagao‐Kitamoto, Nobuhiko Kamada	0
2	Adherent-invasive E. coli – induced specific IgA limits pathobiont localization to the epithelial niche in the gut 2023 ·Frontiers in Microbiology ·Rika Tanaka, Jin Imai, Hitoshi Tsugawa, (unknown), (unknown), (unknown), Masashi Ohno, Kohei Sugihara, Sho Kitamoto, Hiroko Nagao‐Kitamoto, Nicolas Barnich, Masashi Matsushima, Takayoshi Suzuki, Tatehiro Kagawa, Yasuhiro Nishizaki, Hidekazu Suzuki, Nobuhiko Kamada, Katsuto Hozumi	6
3	Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction 2022 ·Cell Reports ·Kohei Sugihara, Sho Kitamoto, Prakaimuk Saraithong, Hiroko Nagao‐Kitamoto, Matthew J. Hoostal, (unknown), (unknown), Chithra Muraleedharan, Merritt Gillilland, Jin Imai, Maiko Omi, Shrinivas Bishu, John Y. Kao, Christopher J. Alteri, Nicolas Barnich, Thomas M. Schmidt, Asma Nusrat, Naohiro Inohara, Jonathan L. Golob, Nobuhiko Kamada	38
4	Inflammatory bowel disease and carcinogenesis 2022 ·Cancer and Metastasis Reviews ·Hiroko Nagao‐Kitamoto, Sho Kitamoto, Nobuhiko Kamada	46
5	DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk 2021 ·Journal of Clinical Investigation ·Helmut Grasberger, Andrew T. Magis, (unknown), Matthew P. Conomos, Min Zhang, (unknown), Guoqing Hou, Shrinivas Bishu, Hiroko Nagao‐Kitamoto, Mohamad El‐Zaatari, Sho Kitamoto, Nobuhiko Kamada, Ryan W. Stidham, Yasutada Akiba, Jonathan D. Kaunitz, Yael Haberman, Subra Kugathasan, Lee A. Denson, Gilbert S. Omenn, John Y. Kao	42
6	Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota 2020 ·Nature Medicine ·Hiroko Nagao‐Kitamoto, Jhansi L. Leslie, Sho Kitamoto, Chunsheng Jin, Kristina A. Thomsson, Merritt Gillilland, Peter Kuffa, Yoshiyuki Goto, Robert R. Jenq, Chiharu Ishii, Akiyoshi Hirayama, Anna M. Seekatz, Eric C. Martens, Kathryn A. Eaton, John Y. Kao, Shinji Fukuda, Peter Higgins, Niclas G. Karlsson, Vincent B. Young, Nobuhiko Kamada	164
7	The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis breakdown → 2020 ·Cell ·Sho Kitamoto, Hiroko Nagao‐Kitamoto, Yizu Jiao, Merritt Gillilland, Atsushi Hayashi, Jin Imai, Kohei Sugihara, (unknown), Jennifer Brazil, Peter Kuffa, Brett Hill, Syed Rizvi, Fei Wen, Shrinivas Bishu, Naohiro Inohara, Kathryn A. Eaton, Asma Nusrat, Yu L. Lei, William V. Giannobile, Nobuhiko Kamada	459
8	IL-10 produced by macrophages regulates epithelial integrity in the small intestine 2019 ·Scientific Reports ·Tina L. Morhardt, Atsushi Hayashi, Takanori Ochi, Miguel Quirós, Sho Kitamoto, Hiroko Nagao‐Kitamoto, Peter Kuffa, Koji Atarashi, Kenya Honda, John Y. Kao, Asma Nusrat, Nobuhiko Kamada	86
9	Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis 2019 ·Mucosal Immunology ·Jin Imai, Sho Kitamoto, Kohei Sugihara, Hiroko Nagao‐Kitamoto, Atsushi Hayashi, Tina L. Morhardt, Peter Kuffa, Peter Higgins, Nicolas Barnich, Nobuhiko Kamada	72
10	Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan 2016 ·Scientific Reports ·Nako Maishi, Yusuke Ohba, Kosuke Akiyama, Noritaka Ohga, Junichi Hamada, Hiroko Nagao‐Kitamoto, Mohammad Towfik Alam, Kazuyuki Yamamoto, Taisuke Kawamoto, Nobuo Inoue, Akinobu Taketomi, Masanobu Shindoh, Yasuhiro Hida, Kyoko Hida	106
11	Functional Characterization of Inflammatory Bowel Disease–Associated Gut Dysbiosis in Gnotobiotic Mice 2016 ·Cellular and Molecular Gastroenterology and Hepatology ·Hiroko Nagao‐Kitamoto, Andrew B. Shreiner, Merritt Gillilland, Sho Kitamoto, Chiharu Ishii, Akiyoshi Hirayama, Peter Kuffa, Mohamad El‐Zaatari, Helmut Grasberger, Anna M. Seekatz, Peter Higgins, Vincent B. Young, Shinji Fukuda, John Y. Kao, Nobuhiko Kamada	176
12	Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine 2016 ·Scientific Reports ·Takanori Ochi, Yongjia Feng, Sho Kitamoto, Hiroko Nagao‐Kitamoto, Peter Kuffa, Koji Atarashi, Kenya Honda, Daniel H. Teitelbaum, Nobuhiko Kamada	43
13	Pathogenic role of the gut microbiota in gastrointestinal diseases 2016 ·Intestinal Research ·Hiroko Nagao‐Kitamoto, Sho Kitamoto, Peter Kuffa, Nobuhiko Kamada	114
14	Intestinal macrophages arising from CCR2+ monocytes control pathogen infection by activating innate lymphoid cells 2015 ·Nature Communications ·Sang‐Uk Seo, Peter Kuffa, Sho Kitamoto, Hiroko Nagao‐Kitamoto, (unknown), Yun‐Gi Kim, Gabriel Núñez, Nobuhiko Kamada	63
15	Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression 2015 ·British Journal of Cancer ·(unknown), Takao Setoguchi, (unknown), Hiroko Nagao‐Kitamoto, Satoshi Nagano, (unknown), Shingo Maeda, Y Ishidou, Takuya Yamamoto, Setsuro Komiya	33
16	Regulation of virulence: the rise and fall of gastrointestinal pathogens 2015 ·Journal of Gastroenterology ·Sho Kitamoto, Hiroko Nagao‐Kitamoto, Peter Kuffa, Nobuhiko Kamada	53
17	Combination of Hedgehog inhibitors and standard anticancer agents synergistically prevent osteosarcoma growth 2015 ·International Journal of Oncology ·(unknown), Takao Setoguchi, (unknown), (unknown), Shunsuke Nakamura, Satoshi Nagano, Yasuhiro Ishidou, Hiroko Nagao‐Kitamoto, Masahiro Yokouchi, Shingo Maeda, Akihide Tanimoto, Tatsuhiko Furukawa, Setsuro Komiya	15
18	Increased Expression of DUOX2 Is an Epithelial Response to Mucosal Dysbiosis Required for Immune Homeostasis in Mouse Intestine 2015 ·Gastroenterology ·Helmut Grasberger, Jun Gao, Hiroko Nagao‐Kitamoto, Sho Kitamoto, Min Zhang, Nobuhiko Kamada, Kathryn A. Eaton, Mohamad El‐Zaatari, Andrew B. Shreiner, Juanita L. Merchant, Chung Owyang, John Y. Kao	112
19	Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion 2014 ·Cancer Letters ·Hiroko Nagao‐Kitamoto, Takao Setoguchi, Sho Kitamoto, Shunsuke Nakamura, (unknown), (unknown), Satoshi Nagano, Yasuhiro Ishidou, Masahiro Yokouchi, Shinichi Kitajima, Takako Yoshioka, Shingo Maeda, Suguru Yonezawa, Setsuro Komiya	41
20	GLI2 is a novel therapeutic target for metastasis of osteosarcoma 2014 ·International Journal of Cancer ·Hiroko Nagao‐Kitamoto, (unknown), Satoshi Nagano, Sho Kitamoto, Yasuhiro Ishidou, Takuya Yamamoto, Shunsuke Nakamura, (unknown), Masahiko Abematsu, Yusuke Fujimoto, Masahiro Yokouchi, Shinichi Kitajima, Takako Yoshioka, Shingo Maeda, Suguru Yonezawa, Setsuro Komiya, Takao Setoguchi	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact